Key clinical point: Look for serum testosterone higher than 630 ng/dL.
Major finding: By month 24, 38% of patients experienced acne.
Study details: A study of 55 female-to-male transgender patients receiving masculinizing doses of testosterone.
Disclosures: The study was funded by a summer research program at Boston University. The authors had no conflicts of interest to report.
Park JA et al. J Am Acad Dermatol. 2019. doi: 10.1016/j.jaad.2018.12.040.